Cargando…

Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation

Detalles Bibliográficos
Autores principales:	Hou, Yafei, Kohanbash, Gary, Okada, Kaori, Shrivastav, Shruti, Smith-Cohn, Matthew, Nicolaides, Theodore, Mueller, Sabine, Carcaboso, Angel, Pollack, Ian, Okada, Hideho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652531/ http://dx.doi.org/10.1186/2051-1426-3-S2-P445

Ejemplares similares

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
por: Chheda, Zinal S., et al.
Publicado: (2018)

IDH mutation-induced suppression of type-1 anti-glioma immune response
por: Kohanbash, Gary, et al.
Publicado: (2015)

IMMU-23. A NOVEL MASS CYTOMETRY-BASED MULTI-PARAMETER CHARACTERIZATION OF NEOANTIGEN-REACTIVE CD8+ T-CELLS IN PATIENTS PARTICIPATING IN PNOC007 H3.3K27M PEPTIDE VACCINE CLINICAL TRIAL
por: Taitt, Jared, et al.
Publicado: (2020)

IMMU-31. PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M DIFFUSE MIDLINE GLIOMAS (DMG)
por: Mueller, Sabine, et al.
Publicado: (2020)

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al
por: Chheda, Zinal S, et al.
Publicado: (2023)

ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth
por: Kohanbash, Gary, et al.
Publicado: (2014)

THER-05. GENETICALLY STABLE POLIOVIRUS VECTOR CARRYING H3.3K27M ANTIGEN FOR TREATMENT OF DIFFUSE MIDLINE GLIOMA BY INTRAMUSCULAR INJECTION
por: Mosaheb, Mubeen, et al.
Publicado: (2020)

Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours
por: Haque, Farhana, et al.
Publicado: (2017)

Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones
por: Sarthy, Jay F, et al.
Publicado: (2020)

Lysine 27 of replication-independent histone H3.3 is required for Polycomb target gene silencing but not for gene activation
por: Leatham-Jensen, Mary, et al.
Publicado: (2019)

Histone H3.3 sub-variant H3mm7 is required for normal skeletal muscle regeneration
por: Harada, Akihito, et al.
Publicado: (2018)

Insulin-Like Growth Factor Binding Protein-3 Binds to Histone 3
por: Bhardwaj, Apurva, et al.
Publicado: (2021)

Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling
por: Chen, Kuang-Yui, et al.
Publicado: (2020)

Histone chaperone ASF1 mediates H3.3-H4 deposition in Arabidopsis
por: Zhong, Zhenhui, et al.
Publicado: (2022)

The in vivo Interaction Landscape of Histones H3.1 and H3.3
por: Siddaway, Robert, et al.
Publicado: (2022)

Histone H3.3 Variant Dynamics in the Germline of Caenorhabditis elegans
por: Ooi, Siew Loon, et al.
Publicado: (2006)

Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines
por: Panigrahy, Ashok, et al.
Publicado: (2022)

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2012)

Histone H3 mutations—a special role for H3.3 in tumorigenesis?
por: Kallappagoudar, Satish, et al.
Publicado: (2015)

Ubinuclein-1 confers histone H3.3-specific-binding by the HIRA histone chaperone complex
por: Daniel Ricketts, M, et al.
Publicado: (2015)

Accumulation of histone variant H3.3 with age is associated with profound changes in the histone methylation landscape
por: Tvardovskiy, Andrey, et al.
Publicado: (2017)

The H3.3K27M oncohistone antagonizes reprogramming in Drosophila
por: Ahmad, Kami, et al.
Publicado: (2021)

Histone H3.3 maintains genome integrity during mammalian development
por: Jang, Chuan-Wei, et al.
Publicado: (2015)

Histone Variant H3.3 Mutations in Defining the Chromatin Function in Mammals
por: Trovato, Matteo, et al.
Publicado: (2020)

Knockout tales: the versatile roles of histone H3.3 in development and disease
por: Klein, Rachel H., et al.
Publicado: (2023)

Extracellular Acetylated Histone 3.3 Induces Inflammation and Lung Tissue Damage
por: Rico, Mario C., et al.
Publicado: (2023)

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
por: Okada, Masahiro, et al.
Publicado: (2022)

Distinct chromatin signature of histone H3 variant H3.3 in human cells
por: Snyers, Luc, et al.
Publicado: (2014)

Cancer immunotherapy‐targeted glypican‐3 or neoantigens
por: Shimizu, Yasuhiro, et al.
Publicado: (2018)

Histone H3.3 phosphorylation promotes heterochromatin formation by inhibiting H3K9/K36 histone demethylase
por: Udugama, Maheshi, et al.
Publicado: (2022)

Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
por: Lewis, Nichole A., et al.
Publicado: (2022)

DIPG-17. TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA USING ALLELE-SPECIFIC SIRNA TARGETING H3.3 K27M MUTANT HISTONE
por: Wentworth, Simon, et al.
Publicado: (2023)

Arabidopsis replacement histone variant H3.3 occupies promoters of regulated genes
por: Shu, Huan, et al.
Publicado: (2014)

The histone variant H3.3 claims its place in the crowded scene of epigenetics
por: Bano, Daniele, et al.
Publicado: (2017)

Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3
por: Lim, Jinyeong, et al.
Publicado: (2018)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Morc3 silences endogenous retroviruses by enabling Daxx-mediated histone H3.3 incorporation
por: Groh, Sophia, et al.
Publicado: (2021)

HGG-33. Prognostic factors of H3K27M histone-mutant diffuse midline gliomas in patients ≤18yrs
por: Hu, Qingjun, et al.
Publicado: (2022)

Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine
por: Najac, Chloé, et al.
Publicado: (2016)

Shared cancer neoantigens: Making private matters public
por: Klebanoff, Christopher A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o5brna4a48j22gq3sl55c4aqhq